Compounds > desthiobiotin
Page last updated: 2024-09-27

desthiobiotin

Description

desthiobiotin: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(4R,5S)-dethiobiotin : The (4R,5S)-isomer of dethiobiotin. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID445027
CHEMBL ID1232381
CHEBI ID42280
SCHEMBL ID143996
SCHEMBL ID20548075
MeSH IDM0045899

Synonyms (72)

Synonym
d-desthiobiotin
MLS001066403 ,
smr000471877
CHEMBL1232381
nsc-3085
dl-dethiobiotin
nsc-203773
636-20-4
biotin, dethio-
ai3-26390
5-methyl-2-oxo-4-imidazolidinecaproic acid
4-methyl-5-(omega-carboxyamyl)imidazolidone-2
(+)-dethiobiotin
d-dethiobiotin
6-(5-methyl-2-oxo-imidazolidin-4-yl)-hexanoic acid
4-imidazolidinehexanoic acid, 5-methyl-2-oxo-, (4r-cis)-
4-imidazolidinehexanoic acid, 5-methyl-2-oxo-, (4r,5s)-
epsilon-(4-methyl-5-imidazolidone-2)caproic acid
5-methyl-2-oxo-4-imidazolidinehexanoic acid
(4r-cis)-5-methyl-2-oxoimidazolidine-4-hexanoic acid
4-imidazolidinehexanoic acid, 5-methyl-2-oxo-, (4r,5s)- (8ci,9ci)
desthiobiotin
DTB ,
533-48-2
d-desthiobiotin, >=98% (tlc)
D1411_SIGMA ,
CHEBI:42280 ,
(4r,5s)-dethiobiotin
DB03775
(4r,5s)-5-methyl-2-oxo-4-imidazolidinehexanoic acid
(4r-cis)-5-methyl-2-oxo-4-imidazolidinehexanoic acid
einecs 208-566-2
F91C55D1-259D-437E-A748-A08C722D274F
6-[(4r,5s)-5-methyl-2-oxoimidazolidin-4-yl]hexanoic acid
BMSE000314
expt01280
nsc 3085
unii-71u5jb52ks
71u5jb52ks ,
HMS2235J03
desthiobiotin [mi]
.epsilon.-(4-methyl-5-imidazolidone-2)caproic acid
desthiobiotin, (+)-
unii-i64p0b487b
i64p0b487b ,
(+/-)-desthiobiotin
desthiobiotin, dl-
desthiobiotin, (+/-)-
4-imidazolidinehexanoic acid, 5-methyl-2-oxo-, cis-(+/-)-
4-imidazolidinehexanoic acid, 5-methyl-2-oxo-, (4r,5s)-rel-
SCHEMBL143996
6-[(4r,5s)-5-methyl-2-oxidanylidene-imidazolidin-4-yl]hexanoic acid
6-[(4r,5s)-5-methyl-2-oxo-4-imidazolidinyl]hexanoic acid
cid_445027
bdbm66184
6-[(4r,5s)-2-keto-5-methyl-imidazolidin-4-yl]hexanoic acid
AKOS030240689
AT20607
rac-desthio biotin
12022-42-3
DTXSID50876136
6-((4r,5s)-5-methyl-2-oxoimidazolidin-4-yl)hexanoic acid
SCHEMBL20548075
Q27094671
HY-128699
CS-0098609
iron potassium sulfide)
BS-48946
mfcd00213804
EN300-19745876
6-((4r,5s)-5-methyl-2-oxoimidazolidin-4-yl)hexanoicacid
(+)-desthiobiotin

Research Excerpts

Overview

ExcerptReference
"Desthiobiotin is a biotin analogue that binds less tightly to biotin-binding proteins and is easily displaced by biotin."( Beechem, JM; Eslamizar, L; Filanoski, BJ; Haugland, RP; Hirsch, JD; Malekzadeh, N, 2002)

Drug Classes (1)

ClassDescription
dethiobiotinA hexanoic acid having a 5-methyl-2-oxoimidazolidin-4-yl group at the 6-position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (16)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency1.00000.631035.7641100.0000AID504339
WRNHomo sapiens (human)Potency24.85320.168331.2583100.0000AID651768; AID720497
Smad3Homo sapiens (human)Potency4.46680.00527.809829.0929AID588855
apical membrane antigen 1, AMA1Plasmodium falciparum 3D7Potency7.94330.707912.194339.8107AID720542
IDH1Homo sapiens (human)Potency58.04790.005210.865235.4813AID686970
Bloom syndrome protein isoform 1Homo sapiens (human)Potency19.18210.540617.639296.1227AID720503
chromobox protein homolog 1Homo sapiens (human)Potency0.70790.006026.168889.1251AID540317
DNA polymerase eta isoform 1Homo sapiens (human)Potency100.00000.100028.9256213.3130AID588591
gemininHomo sapiens (human)Potency0.01160.004611.374133.4983AID624296
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
nonstructural protein 1Influenza A virus (A/California/07/2009(H1N1))IC50 (µMol)1.57000.200024.4540100.0000AID504329
photoreceptor-specific nuclear receptorHomo sapiens (human)IC50 (µMol)0.14910.03742.93408.9620AID2758
nuclear receptor corepressor 2 isoform 2Homo sapiens (human)IC50 (µMol)1.37801.02504.36119.9550AID2759
peroxisome proliferator-activated receptor gamma isoform 2Homo sapiens (human)IC50 (µMol)1.37801.02504.36119.9550AID2759
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
insulin-degrading enzyme isoform 1Homo sapiens (human)EC50 (µMol)7.60152.02605.17858.9430AID588439; AID588681
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
protein AF-9 isoform aHomo sapiens (human)AC500.08000.08008.380217.9800AID720495
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID504787Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): TR-FRET-based biochemical high throughput assay to identify agonists of the interaction between peroxisome proliferator-activated receptor gamma (PPARg) and nuclear rec2006Assay and drug development technologies, Jun, Volume: 4, Issue:3
Development of the high throughput screening assay for identification of agonists of an orphan nuclear receptor.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1674226Inhibition of avidin (unknown origin)2020Journal of medicinal chemistry, 10-22, Volume: 63, Issue:20
Fragment Linking Strategies for Structure-Based Drug Design.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (119)

TimeframeStudies, This Drug (%)All Drugs %
pre-199026 (21.85)18.7374
1990's21 (17.65)18.2507
2000's26 (21.85)29.6817
2010's37 (31.09)24.3611
2020's9 (7.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (3.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other119 (96.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
5-(2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl)pentanoic acid[no description available]medium10biotins
benzbromarone[no description available]medium101-benzofurans;
aromatic ketone		uricosuric drug
9,10-phenanthrenequinone[no description available]medium10phenanthrenes
benzo(b)fluoranthene[no description available]medium10ortho- and peri-fused polycyclic arenemutagen
malononitrile dimer[no description available]medium10
toxoflavin[no description available]medium10carbonyl compound;
pyrimidotriazine		antibacterial agent;
antineoplastic agent;
apoptosis inducer;
bacterial metabolite;
toxin;
virulence factor;
Wnt signalling inhibitor
methyl fluorone black[no description available]medium10
6-hydroxydopa[no description available]medium10non-proteinogenic alpha-amino acid
biotin[no description available]medium1170biotins;
vitamin B7		coenzyme;
cofactor;
Escherichia coli metabolite;
fundamental metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
prosthetic group;
Saccharomyces cerevisiae metabolite
1,3,6-trimethylpyrimido[5,4-e][1,2,4]triazine-5,7-dione[no description available]medium10pyrimidotriazine
5-bromo-3-ethyl-1H-indole-2-carboxylic acid[no description available]medium10indolyl carboxylic acid
2-(4-benzofuro[3,2-d]pyrimidinylthio)-1-thiophen-2-ylethanone[no description available]medium10benzofurans
3,5,5-trimethyl-2-sulfanylidene-1,6-dihydrobenzo[h]quinazolin-4-one[no description available]medium10quinazolines
2-amino-4-(4-chlorophenyl)-6-methyl-3-pyridinecarbonitrile[no description available]medium10phenylpyridine
1,6-dimethyl-3-(2-pyridinyl)pyrimido[5,4-e][1,2,4]triazine-5,7-dione[no description available]medium10pyrimidotriazine
1-(4-methyl-1-piperidinyl)-2-[(3-methyl-2-quinoxalinyl)thio]ethanone[no description available]medium10quinoxaline derivative
N-[3-cyano-4-(4-methoxyphenyl)-5-methyl-2-thiophenyl]-2-methyl-3-pyrazolecarboxamide[no description available]medium10methoxybenzenes
2-(4-fluorophenyl)-3-(2-furanylmethyl)-10-methylpyrimido[4,5-b]quinoline-4,5-dione[no description available]medium10quinolines
6-(4-bromophenyl)-3-methyl-1-[2-(2H-tetrazol-5-yl)ethyl]-4-(trifluoromethyl)pyrazolo[3,4-b]pyridine[no description available]medium10phenylpyridine
3-phenyl-2-sulfanylidene-1H-benzofuro[3,2-d]pyrimidin-4-one[no description available]medium10benzofurans
2-[(4-methylphenyl)sulfonylamino]acetic acid [2-(5-bromo-2-thiophenyl)-2-oxoethyl] ester[no description available]medium10alpha-amino acid ester
2-[(6-chloro-1H-benzimidazol-2-yl)thio]-N-(2,3-dihydro-1H-inden-5-yl)acetamide[no description available]medium10benzimidazoles
2-(4-benzofuro[3,2-d]pyrimidinylthio)-N-(3-methylphenyl)acetamide[no description available]medium10benzofurans
2-amino-7,7-dimethyl-4-(4-methylphenyl)-5-oxo-6,8-dihydro-4H-1-benzopyran-3-carbothioamide[no description available]medium10toluenes
1-(3-methyl-1-piperidinyl)-2-(2-quinoxalinylthio)ethanone[no description available]medium10quinoxaline derivative
2-(5-bromo-2-thiophenyl)-N-(4-methyl-1-piperazinyl)-4-quinolinecarboxamide[no description available]medium10quinolines
3-(4-chloro-1,5-dimethyl-3-pyrazolyl)-4-(4-fluorophenyl)-1H-1,2,4-triazole-5-thione[no description available]medium10triazoles
2-(2-quinoxalinylthio)propanoic acid[no description available]medium10quinoxaline derivative
ellagic acid[no description available]medium10catechols;
cyclic ketone;
lactone;
organic heterotetracyclic compound;
polyphenol		antioxidant;
EC 1.14.18.1 (tyrosinase) inhibitor;
EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor;
EC 2.4.1.1 (glycogen phosphorylase) inhibitor;
EC 2.5.1.18 (glutathione transferase) inhibitor;
EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor;
EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor;
EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
food additive;
fungal metabolite;
geroprotector;
plant metabolite;
skin lightening agent
3-bromo-7-hydroxy-4,8-dimethyl-1-benzopyran-2-one[no description available]medium10hydroxycoumarin
3-(3-methylphenyl)-2-sulfanylidene-1H-benzofuro[3,2-d]pyrimidin-4-one[no description available]medium10benzofurans
6-(4-bromophenyl)-2-methyl-3-pyridinecarboxylic acid[no description available]medium10phenylpyridine
lissamine rhodamine b[no description available]medium10organic sodium saltfluorescent probe;
fluorochrome;
histological dye
methacycline monohydrochloride[no description available]medium10
tacrine[no description available]medium10acridines;
aromatic amine		EC 3.1.1.7 (acetylcholinesterase) inhibitor
acetohydroxamic acid[no description available]medium10acetohydroxamic acids;
carbohydroximic acid		algal metabolite;
EC 3.5.1.5 (urease) inhibitor
benzamidine[no description available]medium10benzenes;
carboxamidine		serine protease inhibitor
n(6),n(6)-dimethyladenine[no description available]medium10tertiary amine
aminosalicylic acid[no description available]medium10aminobenzoic acid;
phenols		antitubercular agent
4-phenylphenol[no description available]medium10hydroxybiphenyls
quinaldic acid[no description available]medium10quinolinemonocarboxylic acidhuman metabolite;
Saccharomyces cerevisiae metabolite
hexanoic acid[no description available]medium10medium-chain fatty acid;
straight-chain saturated fatty acid		human metabolite;
plant metabolite
prolinal[no description available]medium10pyrrolidines
5-Chloro-1H-indole-2,3-dione[no description available]medium10indolesanticoronaviral agent
N(2)-carbamimidoyl-N-{2-[4-(3-{4-[(5-carboxyfuran-2-yl)methoxy]-2,3-dichlorophenyl}-1-methyl-1H-pyrazol-5-yl)piperidin-1-yl]-2-oxoethyl}-D-leucinamide[no description available]medium10D-leucine derivative;
dichlorobenzene;
furoic acid;
glycine derivative;
guanidines;
pyrazolylpiperidine
navitoclax[no description available]medium10aryl sulfide;
monochlorobenzenes;
morpholines;
N-sulfonylcarboxamide;
organofluorine compound;
piperazines;
secondary amino compound;
sulfone;
tertiary amino compound		antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
abt-199[no description available]medium10aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
N-sulfonylcarboxamide;
oxanes;
pyrrolopyridine		antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
caseins[no description available]medium10
methylacetylene[no description available]medium10alkyne;
gas molecular entity;
terminal acetylenic compound
homoserine[no description available]medium10amino acid zwitterion;
homoserine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
dioleoyl phosphatidylethanolamine[no description available]medium10phosphatidylethanolamine
1,2-oleoylphosphatidylcholine[no description available]medium10phosphatidylcholine(1+)
phosphatidylcholines[no description available]medium201,2-diacyl-sn-glycero-3-phosphocholine
serine[no description available]medium10L-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid;
serine zwitterion;
serine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
cysteine[no description available]medium90cysteiniumfundamental metabolite
azides[no description available]medium10pseudohalide anionmitochondrial respiratory-chain inhibitor
urea[no description available]medium20isourea;
monocarboxylic acid amide;
one-carbon compound		Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
thioctic acid[no description available]medium50dithiolanes;
heterocyclic fatty acid;
thia fatty acid		fundamental metabolite;
geroprotector
thiamine[no description available]medium20primary alcohol;
vitamin B1		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
geranyl pyrophosphate[no description available]medium10polyprenyl diphosphateEscherichia coli metabolite;
mouse metabolite
guanidine thiocyanate[no description available]medium10
thiazole orange[no description available]medium10cyanine dyefluorochrome
sepharose[no description available]medium40
glycyl-arginyl-glycyl-aspartyl-serine[no description available]medium10
9-mercaptodethiobiotin[no description available]medium30imidazolidinone;
monocarboxylic acid;
thiol;
ureas		Escherichia coli metabolite
coenzyme a[no description available]medium10adenosine 3',5'-bisphosphatecoenzyme;
Escherichia coli metabolite;
mouse metabolite
adenosine diphosphate[no description available]medium20adenosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate		fundamental metabolite;
human metabolite
pantothenic acid[no description available]medium10pantothenic acid;
vitamin B5		antidote to curare poisoning;
geroprotector;
human blood serum metabolite
dithiothreitol[no description available]medium101,4-dimercaptobutane-2,3-diol;
butanediols;
dithiol;
glycol;
thiol		chelator;
human metabolite;
reducing agent
dithionite[no description available]medium20sulfur oxide;
sulfur oxoanion
methane[no description available]medium10alkane;
gas molecular entity;
mononuclear parent hydride;
one-carbon compound		bacterial metabolite;
fossil fuel;
greenhouse gas
2'-deoxyadenosine[no description available]medium10purine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
s-adenosylhomocysteine[no description available]medium10adenosines;
amino acid zwitterion;
homocysteine derivative;
homocysteines;
organic sulfide		cofactor;
EC 2.1.1.72 [site-specific DNA-methyltransferase (adenine-specific)] inhibitor;
EC 2.1.1.79 (cyclopropane-fatty-acyl-phospholipid synthase) inhibitor;
epitope;
fundamental metabolite
histidine[no description available]medium20amino acid zwitterion;
histidine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
s-adenosylmethionine[no description available]medium70organic cation;
sulfonium compound		coenzyme;
cofactor;
human metabolite;
micronutrient;
Mycoplasma genitalium metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
semapimod[no description available]medium10
tetradecanoylphorbol acetate[no description available]medium10acetate ester;
diester;
phorbol ester;
tertiary alpha-hydroxy ketone;
tetradecanoate ester		antineoplastic agent;
apoptosis inducer;
carcinogenic agent;
mitogen;
plant metabolite;
protein kinase C agonist;
reactive oxygen species generator
aspartic acid[no description available]medium10aspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
mouse metabolite;
neurotransmitter
asparagine[no description available]medium10amino acid zwitterion;
asparagine;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
ethyl isocyanate[no description available]medium10isocyanates
cyanates[no description available]medium10
7,8-diaminopelargonic acid[no description available]medium50amino fatty acid;
amino monocarboxylic acid
thiourea[no description available]medium10one-carbon compound;
thioureas;
ureas		antioxidant;
chromophore
n-methylacetamide-oxotremorine m[no description available]medium10
oxotremorine[no description available]medium10N-alkylpyrrolidine
imidazolone[no description available]medium10organonitrogen heterocyclic compound
sulfur[no description available]medium90chalcogen;
nonmetal atom		macronutrient
7-keto-8-aminopelargonic acid[no description available]medium207-oxo monocarboxylic acid;
amino acid zwitterion;
amino acid		Saccharomyces cerevisiae metabolite
ferric chloride[no description available]medium10iron coordination entityastringent;
Lewis acid
riboflavin[no description available]medium10flavin;
vitamin B2		anti-inflammatory agent;
antioxidant;
cofactor;
Escherichia coli metabolite;
food colouring;
fundamental metabolite;
human urinary metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite
sodium sulfide[no description available]medium10
chlorine[no description available]medium10halide anion;
monoatomic chlorine		cofactor;
Escherichia coli metabolite;
human metabolite
5-deazariboflavin[no description available]medium10
pyrimidine[no description available]medium10diazine;
pyrimidines		Daphnia magna metabolite
lysine[no description available]medium50aspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid		algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
biocytin[no description available]medium50azabicycloalkane;
L-alpha-amino acid zwitterion;
L-lysine derivative;
monocarboxylic acid amide;
non-proteinogenic L-alpha-amino acid;
thiabicycloalkane;
ureas		mouse metabolite
homocysteine[no description available]medium20amino acid zwitterion;
homocysteine;
serine family amino acid		fundamental metabolite;
mouse metabolite
methionine[no description available]medium40aspartate family amino acid;
L-alpha-amino acid;
methionine zwitterion;
methionine;
proteinogenic amino acid		antidote to paracetamol poisoning;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical
choline[no description available]medium20cholinesallergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite
cystine[no description available]medium20
ethionine[no description available]medium10S-ethylhomocysteineantimetabolite;
carcinogenic agent
hydrogen[no description available]medium10elemental hydrogen;
elemental molecule;
gas molecular entity		antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
5'-deoxyadenosine[no description available]medium105'-deoxyribonucleoside;
adenosines		Escherichia coli metabolite;
human metabolite;
mouse metabolite
flag peptide[no description available]medium10peptide
pyridoxal phosphate[no description available]medium10methylpyridines;
monohydroxypyridine;
pyridinecarbaldehyde;
vitamin B6 phosphate		coenzyme;
cofactor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
edetic acid[no description available]medium10ethylenediamine derivative;
polyamino carboxylic acid;
tetracarboxylic acid		anticoagulant;
antidote;
chelator;
copper chelator;
geroprotector
puromycin[no description available]medium10puromycinsantiinfective agent;
antimicrobial agent;
antineoplastic agent;
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor;
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor;
nucleoside antibiotic;
protein synthesis inhibitor
deuterium[no description available]medium10dihydrogen
gramicidin a[no description available]medium10
valinomycin[no description available]medium10cyclodepsipeptide;
macrocycle		antimicrobial agent;
antiviral agent;
bacterial metabolite;
potassium ionophore
mannitol[no description available]medium10mannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent
flavin-adenine dinucleotide[no description available]medium10flavin adenine dinucleotide;
vitamin B2		cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prosthetic group
nad[no description available]medium10organophosphate oxoanioncofactor;
human metabolite;
hydrogen acceptor;
Saccharomyces cerevisiae metabolite
nadp[no description available]medium20
2-iminobiotin[no description available]medium20
potassium chloride[no description available]medium10inorganic chloride;
inorganic potassium salt;
potassium salt		fertilizer
1,2-dipalmitoyl-3-phosphatidylethanolamine[no description available]medium10
1,2-dilauroylphosphatidylcholine[no description available]medium101,2-diacyl-sn-glycero-3-phosphocholine(1+)
carbamates[no description available]medium10amino-acid anion
fluorides[no description available]medium10halide anion;
monoatomic fluorine
aluminum fluoride[no description available]medium10aluminium coordination entity
flavin mononucleotide[no description available]medium10
fructose-1,6-diphosphate[no description available]medium10
azetidyl-2-carboxylic acid[no description available]medium10azetidine-2-carboxylic acid
hydroxyproline[no description available]medium104-hydroxyproline;
L-alpha-amino acid zwitterion		human metabolite;
mouse metabolite;
plant metabolite
proline[no description available]medium10amino acid zwitterion;
glutamine family amino acid;
L-alpha-amino acid;
proline;
proteinogenic amino acid		algal metabolite;
compatible osmolytes;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
malonic acid[no description available]medium10alpha,omega-dicarboxylic acidhuman metabolite
diazomethane[no description available]medium10diazo compoundalkylating agent;
antineoplastic agent;
carcinogenic agent;
poison
pelargonic acid[no description available]medium10medium-chain fatty acid;
straight-chain saturated fatty acid		algal metabolite;
antifeedant;
Daphnia magna metabolite;
plant metabolite
ConditionIndicatedRelationship StrengthStudiesTrials
Alcohol Related Neurodevelopmental Disorder0low10
Alcohol-Related Birth Defects0low10
Anaplastic Astrocytoma0low10
Astrocytoma0low10
Astrocytoma, Grade I0low10
Astrocytoma, Grade II0low10
Astrocytoma, Grade III0low10
Astrocytoma, Protoplasmic0low10
Astrocytoma, Subependymal Giant Cell0low10
Astroglioma0low10
Benign Neoplasms0low20
Cancer0low20
Cancer of Lung0low10
Cancer of the Lung0low10
Carcinoma, Small Cell Lung0low10
Cerebral Astrocytoma0low10
Childhood Cerebral Astrocytoma0low10
Disease Models, Animal0low10
FAE (Fetal Alcohol Effects)0low10
FASD0low10
Fetal Alcohol Spectrum Disorder0low10
Fetal Alcohol Spectrum Disorders0low10
Fetal Alcohol Syndrome0low10
Fibrillary Astrocytoma0low10
Gemistocytic Astrocytoma0low10
Glioma, Astrocytic0low10
Grippe0low10
Growth Retardation, Facial Abnormalities, and Central Nervous System Dysfunction0low10
Human Flu0low10
Human Influenza0low10
Inflammation0low10
Influenza0low10
Influenza in Humans0low10
Influenza, Human0low10
Innate Inflammatory Response0low10
Intracranial Astrocytoma0low10
Juvenile Pilocytic Astrocytoma0low10
Lung Cancer0low10
Lung Neoplasms0low10
Malignancy0low20
Malignant Neoplasms0low20
Mesothelioma0low10
Neoplasia0low20
Neoplasm0low20
Neoplasms0low20
Neoplasms, Benign0low20
Neoplasms, Lung0low10
Neoplasms, Pulmonary0low10
Neuroblastoma0low10
Oat Cell Carcinoma of Lung0low10
Oat Cell Lung Cancer0low10
Oligoastrocytoma, Mixed0low10
Partial Fetal Alcohol Syndrome0low10
Pilocytic Astrocytoma0low10
Pregnancy0low10
Pulmonary Cancer0low10
Pulmonary Neoplasms0low10
Sensitivity and Specificity0low10
Small Cell Cancer Of The Lung0low10
Small Cell Lung Cancer0low10
Small Cell Lung Carcinoma0low10
Subependymal Giant Cell Astrocytoma0low10
Tumors0low20